40.50
2.48%
-1.03
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
51.21%
3.922
|
8.038 | 3.544 | 7.88 | 4.022 |
Operating Expenses
|
10.29%
45.84
|
41.56 | 36.25 | 34.16 | 30.46 |
Benefits Costs and Expenses |
37.88
|
- | - | 31.52 | 28.22 |
Costs And Expenses |
8.87%
37.88
|
41.56 | 36.25 | 31.52 | 28.22 |
Depreciation and Amortization |
16.67%
0.70
|
0.60 | 0.60 | 0.60 | 0.60 |
Operating Income/Loss |
25.03%
-41.92
|
-33.53 | -32.71 | -26.28 | -26.44 |
Nonoperating Income/Loss |
30.82%
7.962
|
6.086 | 4.783 | 2.639 | 2.242 |
Income/Loss From Continuing Operations Before Tax |
522.43%
-33.95
|
8.038 | 3.544 | -23.64 | -24.20 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
23.74%
-33.95
|
-27.44 | -27.93 | -23.64 | -24.20 |
Net Income/Loss
|
23.74%
-33.95
|
-27.44 | -27.93 | -23.64 | -24.20 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
95.66%
2.6038
|
60.00 | 56.25 | 48.37 | 2.2536 |
Diluted Average Shares |
95.66%
2.6038
|
60.00 | 56.25 | 48.37 | 2.2536 |
Basic Earnings Per Share |
13.04%
-0.52
|
-0.46 | -0.50 | -0.49 | -0.54 |
Diluted Earnings Per Share |
13.04%
-0.52
|
-0.46 | -0.50 | -0.49 | -0.54 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):